No connection

Search Results

IBG vs RKDA

IBG
Innovation Beverage Group Limited
BEARISH
Price
$1.06
Market Cap
$1.9M
Sector
Consumer Defensive
AI Confidence
95%
RKDA
Arcadia Biosciences, Inc.
BEARISH
Price
$1.18
Market Cap
$2.4M
Sector
Consumer Defensive
AI Confidence
95%

Valuation

P/E Ratio
IBG
--
RKDA
--
Forward P/E
IBG
--
RKDA
-0.92
P/B Ratio
IBG
0.17
RKDA
0.39
P/S Ratio
IBG
0.66
RKDA
0.5
EV/EBITDA
IBG
-0.4
RKDA
0.41

Profitability

Gross Margin
IBG
76.14%
RKDA
36.04%
Operating Margin
IBG
-121.97%
RKDA
-152.61%
Profit Margin
IBG
-87.72%
RKDA
-48.15%
ROE
IBG
-159.34%
RKDA
-45.14%
ROA
IBG
-32.68%
RKDA
-32.71%

Growth

Revenue Growth
IBG
--
RKDA
-25.9%
Earnings Growth
IBG
--
RKDA
--

Financial Health

Debt/Equity
IBG
0.27
RKDA
--
Current Ratio
IBG
1.14
RKDA
3.09
Quick Ratio
IBG
0.28
RKDA
2.42

Dividends

Dividend Yield
IBG
--
RKDA
--
Payout Ratio
IBG
0.0%
RKDA
0.0%

AI Verdict

IBG BEARISH

IBG exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 3/9 and a catastrophic price collapse of over 93% in the last year. While the company maintains a strong gross margin of 76.14%, this is completely offset by an operating margin of -121.97% and an ROE of -159.34%. The extremely low Price-to-Book ratio (0.17) suggests a value trap rather than a bargain, as the company's liquidity is precarious with a Quick Ratio of only 0.28. Overall, the deterministic indicators and price action signal a high risk of insolvency or further dilution.

Strengths
Strong Gross Margin (76.14%) indicating product-level viability
Low Debt-to-Equity ratio (0.27)
Low Price-to-Sales ratio (0.66)
Risks
Extreme negative profitability (Profit Margin -87.72%)
Severe liquidity risk indicated by Quick Ratio (0.28)
Catastrophic price performance (-98.5% over 5 years)
RKDA BEARISH

RKDA exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. Despite a strong current ratio of 3.09 suggesting short-term liquidity, the company suffers from severe operational inefficiency with an operating margin of -152.61% and declining year-over-year revenue growth of -25.90%. The catastrophic 5-year price decline of -98.8% and a 0/100 technical trend score confirm a persistent bearish trajectory. The stock is currently a classic value trap, trading at a low Price/Book (0.39) but lacking any catalyst for recovery.

Strengths
Strong short-term liquidity (Current Ratio: 3.09)
Positive Gross Margin (36.04%) indicating product viability
Low Price-to-Book ratio (0.39) suggesting deep discount to assets
Risks
Critical fundamental health (Piotroski F-Score: 0/9)
Severe operational losses (Operating Margin: -152.61%)
Negative revenue growth (-25.90% YoY)

Compare Another Pair

IBG vs RKDA: Head-to-Head Comparison

This page compares Innovation Beverage Group Limited (IBG) and Arcadia Biosciences, Inc. (RKDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile